Clinical trial
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization…
NCT00433043 · St. Luke's-Roosevelt Hospital Center, Other · Terminated
Key facts
| NCT number | NCT00433043 |
|---|---|
| Title | BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT) |
| Official title | Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System |
| Lead sponsor | St. Luke's-Roosevelt Hospital Center, Other |
| Collaborators | Medtronic Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug, Procedure |
| Interventions | Beta blocker (carvedilol or metoprolol succinate), CRT (cardiac resynchronization therapy) |
| Enrollment | 2 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Feb 9, 2007 |
| Last update posted | Oct 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: